Lobbying Filing Details
Total Spending
$60,000
Activities
1
Lobbyists
2
Gov't Entities
2
Filing Information
- Filing UUID:
a9383920-bde3-4465-8e78-108141ef613d- Type:
- Q2 - 2nd Quarter - Report
- Period:
- 2026 - 2nd Quarter (Apr 1 - June 30)
- Date Posted:
- July 20, 2026 at 3:02 PM
- Income:
- $60,000
- Expenses:
- $0
- Document URL:
- View Submission
Quick Info
- Document Type: text/html
- Posted By: Brian Pomper
Registrant
AKIN GUMP STRAUSS HAUER & FELD
Law firm
WASHINGTON, District of ColumbiaClient
KYVERNA THERAPEUTICS, INC.
Biopharmaceutical company focused on developing cell therapies for autoimmune diseases.
California, United States of AmericaLobbying Activities (1)
Activity 1
Health IssuesIssues related to developing cell therapies for patients, including Stiff Person Syndrome, rare disease, and Multiple Sclerosis; Issues related to H.R. 8646 - Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027.
Lobbyists (2)
- ANNA ABRAM
- KANDIS MCCLURE
Government Entities (2)
- SENATE
- HOUSE OF REPRESENTATIVES